Position Statements
Artificial Intelligence (AI)
Bioethics
Lilly strives to maintain the highest standards of bioethical behaviour. We believe we have a responsibility to protect the rights and welfare of patients and research participants, to treat animals ethically, and to preserve the integrity of the scientific process in the design, conduct and communication of our research.
Strong policies and principles support our goal to ensure that research conducted by employees or third parties aligns with our values and comply with relevant local, national and transnational laws and regulations.
More information:
Lilly’s Bioethics Program
Business Ethics
Inclusion
Cultivating an inclusive culture enables us to attract and keep the best talent, fuels innovation necessary for the next breakthrough medicine, and strengthens our understanding of the patients who depend on us. We deeply value diverse backgrounds, skills and global perspectives, and will continue to be guided by our core values of integrity, excellence and respect for people.
More information:
Cultivating an inclusive culture
Environment and climate change
Our purpose is to make life better, and that includes protecting and preserving the world we live in. Making medicines requires the use of valuable resources, including energy, water and raw materials. We are working to reduce our environmental impact across the life cycles of our medicines and supply chain. This includes establishing 2030 improvement goals for climate, waste and water. To track progress, we measure and manage energy and water use, greenhouse gas emissions and the generation of waste and wastewater throughout the manufacturing process.
More information:
Our Environmental Approach
Healthcare access
Human rights
We support the United Nations Global Compact’s Ten Principles on respecting internationally proclaimed human rights. One of our long-established core values – respect for people – guides us to maintain and uphold an environment built on mutual respect, openness and individual integrity. This includes our concern for all people who touch or are touched by our company – patients, customers, employees, shareholders, partners, suppliers and communities. Our purpose is to unite caring with discovery to make life better for people around the world. While this encapsulates discovering innovative medicines, it also guides our efforts for employees, partners and suppliers to uphold our values and respect human rights as we work together to improve lives.
More information:
Human Rights
Operating ethically and responsibly
We set high standards for our products, operations and performance, and we are always seeking opportunities to enhance these areas.
Our robust code of conduct, policies and procedures governing behavior in the workplace – along with required employee annual training in ethical business practices – reinforce a culture of integrity and ethical behavior. We encourage employees to seek guidance when the ethical or legal thing to do is not clear and to report any concerns in a timely manner.
Employees can report concerns to leadership, human resources, ethics and compliance, or legal. The Lilly Ethics and Compliance Hotline is available 24 hours a day to employees and the public globally, subject to local law via this website. You can find up-to-date local phone numbers for most countries, where available, and you will be prompted with instructions for submitting a report consistent with local process. Translation services are available, and reports may be made anonymously.
More information:
Operate Ethically and Responsibly
Business Ethics
About Lilly
Patient safety
Our goal is to ensure safety and effectiveness of our medicines, beginning with the discovery of a potential new medicine and continuing as long as it is available to patients.
Our approach to medical safety is rooted in evidence, science and ethics. We prioritise patient well-being in our decision-making and emphasise transparency.
We want to ensure that our medicines are continuously monitored and that regulators, health care providers, and patients understand the benefits and risks.
Our Global Patient Safety organisation is dedicated to the collection, monitoring, evaluation and reporting of safety information, and we communicate new safety findings to patients, health care professionals and regulators.
We’re committed to manufacturing high-quality medicines. We carefully monitor our manufacturing facilities to meet current Good Manufacturing Practices and quality manufacturing standards set by the U.S. Food and Drug Administration (FDA), the Therapeutics Goods Administration (TGA) and other regulatory agencies around the world.
More information:
What We’re Doing to Help Keep Patients Safe